Copy
View this email in your browser

Associate Professor
James Lee

General and Endocrine Surgeon,
The Alfred, Monash Health,
Epworth Healthcare

“The evolving role of molecular markers in the management of patients with thyroid cancer”

Molecular markers have been playing an increasing role in the management of patients with thyroid cancer – from diagnosis, prognosis, to treatment or advanced disease. In this seminar, A/Prof James Lee will provide an overview of the evolving role of molecular markers in the management of patients with thyroid cancer.

Thursday 9 December 2021
1pm to 2pm

Register for this seminar
Monash Partners Comprehensive Cancer Consortium (MPCCC) is a strategic alliance of health service and research organisations working in partnership to improve cancer outcomes through integrated, collaborative and innovative research and clinical care programs.
Twitter
Website
LinkedIn
Copyright © 2021 MPCCC, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp